Paragon Bioservices, Inc.
Dennis Fasciani currently serves as a Senior Quality Assurance Specialist at Catalent Pharma Solutions since December 2018. In this role, Dennis leads the QA Raw Material specification group, overseeing the writing and revision of raw material specifications, managing multiple projects simultaneously, and ensuring timely material needs are met through collaboration with stakeholders. Additionally, Dennis is responsible for interdepartmental project leadership, employee management, and communication with third-party vendors. Previous experience includes various quality assurance roles at Paragon Bioservices and Osiris Therapeutics. Dennis holds a Bachelor of Science in Biochemistry and Molecular Biology from the University of Maryland Baltimore County.
Paragon Bioservices, Inc.
With deep experience in viral vector scale-up and production, Catalent Cell & Gene Therapy is a full-service partner for adeno-associated virus (AAV) and lentiviral vectors, and CAR-T immunotherapies. When it acquired MaSTherCell, Catalent added expertise in autologous and allogeneic cell therapy development and manufacturing to position it as a premier technology, development and manufacturing partner for innovators across the entire field of advanced biotherapeutics. Catalent has a global cell and gene therapy network of dedicated, large-scale clinical and commercial manufacturing facilities, and fill-finish and packaging capabilities located in both the U.S. and Europe. An experienced partner, Catalent Cell & Gene Therapy has worked with industry leaders across 70+ clinical and commercial programs.